ViroPharma to Present at Two June Healthcare Conferences

http://ac-review.blogspot.com
June 2 /PRNewswire-FirstCall/ -- , MD, vice presideng and chief scientific officerof ViroPharma, will presentf at the 30th Annual Goldman Sachs Global Healthcare Conference at 3:45 P.M. ET on June 9, 2009. The conference is being held at the Grancd Hyatt in NewYork , vice president, corporate communications will present at the Jefferiees & Company 3rd Annual Healthcarse Conference at 10:15 A.M. ET on June 18, 2009. The conference is being held at the Mandarin Orientapl in NewYork City. ViroPharma's presentations will be webcast live for investors through and availablew for a period of 14 days followingthe conferences.
ViroPharmwa Incorporated is a biopharmaceutical company dedicate d to the development and commercialization of products that addresxs serious diseases treated by physician specialists and inhospitao settings. ViroPharma commercializes Vancocin(R), approved for oral administrationj for treatmentof antibiotic-associated pseudomembranous colitis causex by Clostridium difficile and enterocolitis causedd by Staphylococcus aureus, including methicillin-resistant ViroPharma commercializes Cinryze(TM) (C1 esterasre inhibitor (human)) for routine prophylaxis against angioedemaa attacks in adolescent and adult patients with hereditaryu angioedema (HAE), also known as C1 inhibitod deficiency (for prescribing information on ViroPharma's commercial please download the package inserts at ).
ViroPharmsa currently focuses its drug developmentg activities in diseases includingcytomegalovirus (CMV), HAE and C. ViroPharma routinely posts information, including press which may be important to investors in the investodr relations and media sections ofour company'sa web site, . The company encourages investorsz to consult these sections for more informatiomn on ViroPharma andour